Hejazi Andre, Willis Connor, Ye Xiangyang, Youssef Jim, Moebus Chip, Goss Ben, Cornwall Bryan, Brodke Darrel, McCormick Zachary L, Schaecher Kenneth, Brixner Diana
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Mainstay Medical, San Diego, CA, USA.
Interv Pain Med. 2024 Nov 14;3(4):100522. doi: 10.1016/j.inpm.2024.100522. eCollection 2024 Dec.
Patients with mechanical chronic lower back pain (CLBP) have few durable treatment options for their condition and thus suffer decreased productivity and have higher healthcare resource utilization (HRU) compared to patients without CLBP. The economic burden of treatment and ongoing care for CLBP is considerable, with healthcare spending in 2016 estimated at $134.5 billion in the United States.
This study aims to assess the correlation between patient-reported physical function scores and HRU in patients treated for mechanical CLBP.
This was a retrospective cohort study within a university-based health system.
Patients with a diagnosis of mechanical CLBP from 2015 through 2020 (index date) who were non-surgical candidates at baseline were included in this study. To ensure the presence of low back pain, patients were required to have encounters between 6 and 12 months as well as between 12 and 24 months following the date of CLBP diagnosis.
Collected data variables included patient baseline characteristics, Patient-Reported Outcomes Measurement Information System - Physical Function (PROMIS-PF) scores, pharmacologic and non-pharmacologic therapies, HRU, and healthcare charges between January 2015 through December 2022.
PROMIS-PF scores were converted to numerical categories ranging from 0 to 3, with Category 0 representing the lowest physical function and Category 3 the highest physical function. Patients were more broadly stratified into Low Physical Function (Low-PF) (Category 0-1) or High-Physical Function(High-PF) (Category 2-3) cohorts. HRU was compared between the Low-PF and High-PF cohorts using linear regression analyses. A mixed-effects regression analysis comparing Low-PF and High-PF patients was performed to model the relationship between patient-reported physical function and healthcare charges. The model is able to estimate charges for a base-case patient and can be adjusted to include patient-specific characteristics.
A total of 2765 patients were included in this study, mean age was 50.1 (SD:17.7) years old, 23.6 % were 65 years or older, 68.4 % were female, and 85.3 % were white. Median healthcare charges by PROMIS-PF categories for Year-1 were highest for Category 0 patients ($14,028 [IQR: $5190-38,289]) and lowest for Category 3 ($5352 [IQR: $2417-14,470]). Patients in the Low-PF cohort showed significantly higher rates of all-cause, inpatient stays, outpatient visits, and emergency department (ED) visits compared to High-PF patients. The mixed effects regression model estimated cumulative healthcare charges to be > 2-fold higher for a base-case patient in the Low-PF cohort compared to High-PF. A small portion of patients (n = 14) failed treatment strategies and went on to receive CLBP-surgery despite not having surgical indications at baseline. Median healthcare charges from the 3-month period surrounding date of surgery were $59,809 (IQR: $46,057-85,484).
Cumulative Year-1 healthcare charges were almost 3-fold higher in Low-PF patients compared to High-PF. The mixed effects regression model estimated cumulative 2-year charges to be over 2-fold higher for Low-PF compared to High-PF, in the base-case patient. There were significantly higher rates of all-cause inpatient, outpatient, and ED visits in the year following diagnosis of mechanical CLBP for Low-PF patients. Despite receiving treatment, some patients went on to receive costly surgical procedures over the course of follow-up.
机械性慢性下腰痛(CLBP)患者针对其病情的持久治疗选择很少,因此与无CLBP的患者相比,他们的生产力下降,医疗资源利用率(HRU)更高。CLBP的治疗和持续护理的经济负担相当大,2016年美国的医疗支出估计为1345亿美元。
本研究旨在评估接受机械性CLBP治疗的患者中,患者报告的身体功能评分与HRU之间的相关性。
这是一项基于大学健康系统的回顾性队列研究。
本研究纳入了2015年至2020年(索引日期)诊断为机械性CLBP且基线时不适合手术的患者。为确保存在下腰痛,要求患者在CLBP诊断日期后的6至12个月以及12至24个月之间有就诊记录。
收集的数据变量包括患者基线特征、患者报告结局测量信息系统 - 身体功能(PROMIS-PF)评分、药物和非药物治疗、HRU以及2015年1月至2022年12月期间的医疗费用。
PROMIS-PF评分被转换为0至3的数字类别,0类代表最低身体功能,3类代表最高身体功能。患者被更广泛地分层为低身体功能(Low-PF)(0-1类)或高身体功能(High-PF)(2-3类)队列。使用线性回归分析比较Low-PF和High-PF队列之间的HRU。进行了一项比较Low-PF和High-PF患者的混合效应回归分析,以建立患者报告的身体功能与医疗费用之间的关系模型。该模型能够估计基础病例患者的费用,并可进行调整以纳入患者特定特征。
本研究共纳入2765例患者,平均年龄为50.1(标准差:17.7)岁,23.6%为65岁及以上,68.4%为女性,85.3%为白人。第1年按PROMIS-PF类别划分的医疗费用中位数,0类患者最高(14,028美元[四分位间距:5190-38,289美元]),3类患者最低(5352美元[四分位间距:2417-14,470美元])。与High-PF患者相比,Low-PF队列中的患者全因住院、门诊就诊和急诊科(ED)就诊率显著更高。混合效应回归模型估计,基础病例的Low-PF队列患者的累计医疗费用比High-PF队列高2倍以上。一小部分患者(n = 14)治疗策略失败,尽管基线时没有手术指征,但仍继续接受CLBP手术。手术日期前后3个月期间的医疗费用中位数为59,809美元(四分位间距:46,057-85,484美元)。
与High-PF患者相比,Low-PF患者第1年的累计医疗费用高出近3倍。混合效应回归模型估计,基础病例中Low-PF患者的累计2年费用比High-PF患者高出2倍以上。在诊断为机械性CLBP后的一年中,Low-PF患者的全因住院、门诊和ED就诊率显著更高。尽管接受了治疗,但在随访过程中,一些患者仍继续接受了昂贵的手术。